Seritage Growth Properties is a reit-retail business based in the US. Seritage Growth Properties shares (SRG) are listed on the NYSE and all prices are listed in US Dollars. Seritage Growth Properties employs 40 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Active traders
| Latest market close | $5.56 |
|---|---|
| 52-week range | $4.90 - $17.75 |
| 50-day moving average | $8.12 |
| 200-day moving average | $11.80 |
| Wall St. target price | $16.00 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-1.79 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $5.56 from 2022-07-05
| 1 week (2022-06-30) | 6.72% |
|---|---|
| 1 month (2022-06-06) | -27.13% |
| 3 months (2022-04-04) | -57.88% |
| 6 months (2022-01-07) | -57.23% |
| 1 year (2021-07-07) | -66.65% |
|---|---|
| 2 years (2020-07-07) | -46.74% |
| 3 years (2019-07-05) | 44.27 |
| 5 years (2017-07-06) | 41.78 |
| Revenue TTM | $105.8 million |
|---|---|
| Gross profit TTM | $27.2 million |
| Return on assets TTM | -1.58% |
| Return on equity TTM | -11.53% |
| Profit margin | -68.67% |
| Book value | $14.54 |
| Market capitalisation | $296.2 million |
TTM: trailing 12 months
We're not expecting Seritage Growth Properties to pay a dividend over the next 12 months.
Seritage Growth Properties's shares were split on a 10:1 basis on 14 February 2006. So if you had owned 1 share the day before before the split, the next day you'd have owned 10 shares. This wouldn't directly have changed the overall worth of your Seritage Growth Properties shares – just the quantity. However, indirectly, the new 90% lower share price could have impacted the market appetite for Seritage Growth Properties shares which in turn could have impacted Seritage Growth Properties's share price.
Over the last 12 months, Seritage Growth Properties's shares have ranged in value from as little as $4.9 up to $17.75. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Seritage Growth Properties's is 2.1352. This would suggest that Seritage Growth Properties's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Seritage Growth Properties is a publicly-traded, self-administered and self-managed REIT with 166 wholly-owned properties and 29 unconsolidated properties totaling approximately 30. 4 million square feet of space across 44 states and Puerto Rico. The Company was formed to unlock the underlying real estate value of a high-quality retail portfolio it acquired from Sears Holdings in July 2015. The Company's mission is to create and own revitalized shopping, dining, entertainment and mixed-use destinations that provide enriched experiences for consumers and local communities, and create long-term value for our shareholders. .
Everything we know about the Citrine Global IPO, plus information on how to buy in.
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.